About TherapeuticsMD
TherapeuticsMD is a company based in Boca Raton (United States) founded in 2008 by Brian Bernick was acquired by EW Healthcare Partners in May 2022. TherapeuticsMD has raised $7.5 million across 9 funding rounds from investors including MidCap Financial, Rubric Capital and Sixth Street. The company has 1 employees. TherapeuticsMD has completed 1 acquisition, including VitaMed MD.
- Headquarter Boca Raton, United States
- Employees 1
- Founders Brian Bernick
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website therapeuticsmd.com
- Social LinkedIn X Facebook
- Acquired by EW Healthcare Partners (May 2022)
- Legal Name Therapeuticsmd, Inc.
- Annual Revenue$3.02 M (USD)71.61as on Dec 31, 2025
- Net Profit-$569 K (USD)73.91as on Dec 31, 2025
- EBITDA-$3.02 M (USD)-1.27as on Dec 31, 2025
- Total Equity Funding$7.5M (USD)
in 9 rounds
- Latest Funding Round$1.15M (USD), Post-IPO
Jun 2023
- InvestorsMidCap Financial
& 3 more
- Employee Count1
- Investments & Acquisitions
- Acquired byEW Healthcare Partners
(May 2022)
Funding Insights of TherapeuticsMD
TherapeuticsMD has successfully raised a total of $7.5M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.15 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.5M
- Total Rounds 9
- Last Round Post-IPO — $1.15M
- First Round $8.5M
(Oct 2012)
- Investors Count 3
All 9 funding rounds of TherapeuticsMD with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2023 | $1.15M | Post-IPO | – | – | – |
| Oct 2022 | $7M | Post-IPO | – | – | |
| Aug 2022 | $15M | Post-IPO | – | – | |
| Aug 2020 | $7.5M | Series A | – | – | – |
| Apr 2019 | $300M | Debt – Conventional | – | – | |
| Jun 2018 | $75M | Debt – Conventional | – | – | |
| Jan 2016 | $144M | Post-IPO | – | – | – |
| Oct 2013 | $33M | Post-IPO | – | – | – |
| Oct 2012 | $8.5M | Post-IPO | – | – | – |
4 investors in total: 4 institutional.
Investors in TherapeuticsMD
TherapeuticsMD has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include MidCap Financial, Rubric Capital and Sixth Street.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and debt investments are managed across multiple sectors. | – | sixthstreet.com | San Francisco, United States | |
Private debt funds are managed across multiple sectors. | 2008 | midcapfinancial.com | Bethesda, United States | |
Growth-stage healthcare companies are invested in by EW Healthcare Partners. | – | ewhealthcare.com | New York, United States | |
Investment management services are offered by Rubric Capital. | – | rubriccapital.com | New York, United States |
Investor details for TherapeuticsMD
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TherapeuticsMD
14 people are tracked at TherapeuticsMD (4 in leadership, 5 in board & advisors, 5 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Brian Bernick | Co-Founder | Leadership |
Marlan W | CEO | Leadership |
Marlan Walker | CEO | Leadership |
Kenny Johnson | Regional Business Director - Pacific Northwest | Leadership |
Gail Naughton | Director | Board & advisors |
J. Martin Carroll | Director | Board & advisors |
Tommy G. Thompson | Chairman Of The Board | Board & advisors |
Cooper C. Collins | Director | Board & advisors |
Justin H. Roberts | Director | Board & advisors |
Heather Greeley | Women’s Healthcare Speciality Representative | Team |
Michaela Schelzi | Business Development Manager | Team |
Joe Ziegler | Principle Financial Officer | Team |
Miller Burns | Specialty Pharmaceutical Sales Representative | Team |
Felicity McKenzie | Business Development Manager | Team |
Complete people profiles for TherapeuticsMD
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of TherapeuticsMD
TherapeuticsMD is a publicly listed company on the NASDAQ with ticker symbol TXMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date31 Jan 2001
- Listed onNASDAQ: TXMD
- Listed entityTherapeuticsMD, Inc.
- Exchange sectorHealth technology
- ISINUS88338N2062
- Share price$1.96 (-2.97% on the day) · 2026-10-13
- Market capitalisation$22.7M
- Price to earnings63.6
- EPS (diluted, trailing year)$-0.02
- Volume (last session)29,109
Financials of TherapeuticsMD
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $3.0M | -$569,000 | -$3.0M |
| 2024 | $1.8M | -$2.2M | -$3.0M |
| 2023 | $1.3M | -$10.3M | -$7.6M |
| 2022 | $70.0M | -$93.4M | $11.9M |
| 2021 | $2.6M | -$172.4M | -$78.8M |
Detailed financial statements for TherapeuticsMD
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TherapeuticsMD
TherapeuticsMD has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include VitaMed MD.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pre-natal vitamins are provided by online pharmacy at discounted prices. | vitamedmd.com | Boca Raton, United States | 2008 | Oct 2011 | •••• |
Complete acquisition details for TherapeuticsMD
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of TherapeuticsMD
6 dated milestones of TherapeuticsMD across 22 years, from founding to its latest funding, stage changes and deals.
- IPO Lists on the stock exchange (IPO).
- Founded TherapeuticsMD is founded.
- Acquisition Acquires VitaMed MD.
- Funding First funding round of $8.5M.
- Exit Acquired by EW Healthcare Partners.
- Funding Latest funding round, Post-IPO, of $1.1M.
Web traffic of TherapeuticsMD
The website of TherapeuticsMD (therapeuticsmd.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▲ 59.2% vs previous month
Websites whose visitors overlap most with TherapeuticsMD. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| factset.com | 100% | 1.7M | #36,523 | View details |
Latest news on Therapeuticsmd
Complete news archive for TherapeuticsMD
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to TherapeuticsMD
10 companies that operate in the same segment as TherapeuticsMD (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TherapeuticsMD
TherapeuticsMD was founded in 2008 and raised its 1st funding round 4 years after it was founded.
TherapeuticsMD is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
Marlan W is the current CEO of TherapeuticsMD.
TherapeuticsMD is a funded company, having raised a total of $7.5M across 9 funding rounds to date. The company's 1st funding round was a Post-IPO of $8.5M, raised on Oct 2012.
TherapeuticsMD has 1 employees.
Annual revenue of TherapeuticsMD is $3.02M as on Dec 31, 2025.
TherapeuticsMD was founded in 2008 and is based in Boca Raton, United States. Branded and generic prescription pharmaceuticals, along with over-the-counter products, are developed and distributed exclusively for womens health needs. Operations are conducted within the healthcare sector, emphasizing solutions for female-specific conditions. Leadership includes co-founder Brian Bernick and CEO Marlan W, guiding focus on targeted therapeutic offerings.
Yes, TherapeuticsMD is publicly traded on NASDAQ under the ticker symbol TXMD.
TherapeuticsMD has made 1 acquisition, including VitaMed MD.
TherapeuticsMD has 4 investors. Key investors include MidCap Financial, Rubric Capital, Sixth Street, and EW Healthcare Partners.
Yes. TherapeuticsMD was acquired by EW Healthcare Partners in May 2022.